1. Evaluation of antidepressant properties of the p38 MAP kinase inhibitor losmapimod (GW856553) in Major Depressive Disorder: Results from two randomised, placebo-controlled, double-blind, multicentre studies using a Bayesian approach. (June 2014) Authors: Inamdar, Amir; Merlo-Pich, Emilio; Gee, Michelle; Makumi, Clare; Mistry, Prafull; Robertson, Jon; Steinberg, Erik; Zamuner, Stefano; Learned, Susan; Alexander, Robert; Ratti, Emiliangelo Journal: Journal of psychopharmacology Issue: Volume 28:Number 6(2014:Jun.) Page Start: 570 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗